THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Anjan Pradhan to Mice

This is a "connection" page, showing publications Anjan Pradhan has written about Mice.
Connection Strength

0.717
  1. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1?. Proc Natl Acad Sci U S A. 2021 05 25; 118(21).
    View in: PubMed
    Score: 0.097
  2. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF. Proc Natl Acad Sci U S A. 2019 03 19; 116(12):5687-5692.
    View in: PubMed
    Score: 0.083
  3. Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway. Mol Cancer Ther. 2018 09; 17(9):1951-1960.
    View in: PubMed
    Score: 0.079
  4. mda-7/IL-24 Mediates Cancer Cell-Specific Death via Regulation of miR-221 and the Beclin-1 Axis. Cancer Res. 2017 02 15; 77(4):949-959.
    View in: PubMed
    Score: 0.071
  5. Physical and functional interaction of the proto-oncogene EVI1 and tumor suppressor gene HIC1 deregulates Bcl-xL mediated block in apoptosis. Int J Biochem Cell Biol. 2014 Aug; 53:320-8.
    View in: PubMed
    Score: 0.060
  6. EVI1 targets platelet endothelial cell adhesion molecule and up-regulates its expression in chronic myeloid leukemia. Leuk Lymphoma. 2014 Apr; 55(4):954-6.
    View in: PubMed
    Score: 0.056
  7. Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis. PLoS One. 2011; 6(9):e25370.
    View in: PubMed
    Score: 0.050
  8. EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1. Biochim Biophys Acta. 2011 Apr-Jun; 1809(4-6):269-75.
    View in: PubMed
    Score: 0.048
  9. Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus. J Cell Physiol. 2024 Aug; 239(8):e31302.
    View in: PubMed
    Score: 0.030
  10. Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity. J Immunother Cancer. 2023 11; 11(11).
    View in: PubMed
    Score: 0.029
  11. Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy. Cancer Res. 2021 05 01; 81(9):2429-2441.
    View in: PubMed
    Score: 0.024
  12. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor. Mol Cancer Ther. 2019 11; 18(11):1997-2007.
    View in: PubMed
    Score: 0.021
  13. Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy. Cancer Lett. 2017 03 01; 388:292-302.
    View in: PubMed
    Score: 0.018
  14. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells. Oncotarget. 2016 Aug 23; 7(34):54102-54119.
    View in: PubMed
    Score: 0.017
  15. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis. Oncotarget. 2016 Jul 26; 7(30):46848-46861.
    View in: PubMed
    Score: 0.017
  16. mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM. Cancer Res. 2016 06 15; 76(12):3572-82.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES